EDGAR Filing Documents for 0001193125-13-028708

Form 8-K - Current report:

SEC Accession No. 0001193125-13-028708

Filing Date

2013-01-30

Accepted

2013-01-29 20:58:11

Documents

Period of Report

2013-01-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d476053d8k.htm	8-K	31237
2	ARTICLES OF AMENDMENT TO 2002 RESTATED ARTICLES OF INCORPORATION	d476053dex31.htm	EX-3.1	52741
3	SERIES H CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT	d476053dex101.htm	EX-10.1	190099
4	REGISTRATION RIGHTS AGREEMENT	d476053dex102.htm	EX-10.2	92379
	Complete submission text file	0001193125-13-028708.txt		367958

Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062

Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001

BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)